SMALL CELL CARCINOMA OF THE BLADDER
Clinical trials for SMALL CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bladder cancer: drug combo trial launches
Disease control Recruiting nowThis study tests two drugs, lurbinectedin and avelumab, in people with a rare and aggressive bladder cancer called small cell carcinoma. The goal is to see if these drugs can shrink tumors or slow the disease. Participants will receive treatment every 3 weeks for up to 10 years, …
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug combo offers hope for rare genitourinary cancers
Disease control Recruiting nowThis study tests whether two approved cancer drugs, sacituzumab govitecan and atezolizumab, can shrink or control rare tumors of the bladder, kidney, ureters, and penis. About 60 adults with these uncommon cancers will receive the drugs through an IV, either alone or together. Th…
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC